SCHEMBL31667085

SCHEMBL31667085

Nn1c(=O)oc2cc(CN3C(=O)c4ccccc4C3Cc3ncccc3Br)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ PKM P14618 1/20 0.33
▸ MAPT P10636 3/20 0.32
▸ LMNA P02545 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PRMT5 O14744 3/20 0.32
▸ WDR77 Q9BQA1 3/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ SCN5A Q14524 1/20 0.31
▸ SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686957 0.83 TNIK (0.33) MAPK1ALDH1A1NPC1TNIKKDM4E
SCHEMBL31667444 0.82 IL4I1 (0.37) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31667004 0.82 IL4I1 (0.37) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31667648 0.82 IL4I1 (0.37) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31666998 0.82 HPGD (0.36) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31666987 0.80 PRMT5 (0.36) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31667200 0.79 ALDH1A1 (0.40) HPGDMAPK1ALDH1A1PKMMAPT
SCHEMBL31667171 0.79 PRMT5 (0.35) HPGDMAPK1ALDH1A1MAPTPRMT5
SCHEMBL31667164 0.79 MAPT (0.40) MAPK1ALDH1A1PKMMAPTMEN1
SCHEMBL31667014 0.78 PRMT5 (0.38) HPGDMAPK1ALDH1A1PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 HPGD 520/4885MAPK1 1908/4885ALDH1A1 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback